全文获取类型
收费全文 | 1339篇 |
免费 | 79篇 |
国内免费 | 147篇 |
专业分类
儿科学 | 58篇 |
妇产科学 | 5篇 |
基础医学 | 103篇 |
口腔科学 | 23篇 |
临床医学 | 171篇 |
内科学 | 253篇 |
皮肤病学 | 177篇 |
神经病学 | 60篇 |
特种医学 | 309篇 |
外科学 | 47篇 |
综合类 | 24篇 |
预防医学 | 59篇 |
眼科学 | 13篇 |
药学 | 209篇 |
1篇 | |
肿瘤学 | 53篇 |
出版年
2023年 | 3篇 |
2022年 | 3篇 |
2021年 | 4篇 |
2020年 | 6篇 |
2019年 | 12篇 |
2018年 | 22篇 |
2017年 | 11篇 |
2016年 | 19篇 |
2015年 | 23篇 |
2014年 | 25篇 |
2013年 | 48篇 |
2012年 | 29篇 |
2011年 | 35篇 |
2010年 | 41篇 |
2009年 | 51篇 |
2008年 | 31篇 |
2007年 | 120篇 |
2006年 | 32篇 |
2005年 | 33篇 |
2004年 | 17篇 |
2003年 | 16篇 |
2002年 | 26篇 |
2001年 | 30篇 |
2000年 | 26篇 |
1999年 | 40篇 |
1998年 | 88篇 |
1997年 | 76篇 |
1996年 | 73篇 |
1995年 | 66篇 |
1994年 | 47篇 |
1993年 | 53篇 |
1992年 | 17篇 |
1991年 | 24篇 |
1990年 | 20篇 |
1989年 | 59篇 |
1988年 | 42篇 |
1987年 | 34篇 |
1986年 | 32篇 |
1985年 | 37篇 |
1984年 | 24篇 |
1983年 | 17篇 |
1982年 | 31篇 |
1981年 | 22篇 |
1980年 | 21篇 |
1979年 | 13篇 |
1978年 | 6篇 |
1977年 | 17篇 |
1976年 | 28篇 |
1975年 | 14篇 |
1969年 | 1篇 |
排序方式: 共有1565条查询结果,搜索用时 62 毫秒
1.
2.
3.
Adverse reaction to intravenous gadoteridol 总被引:1,自引:0,他引:1
4.
5.
6.
7.
Intestinal schistosomiasis japonica: CT-pathologic correlation 总被引:1,自引:0,他引:1
Lee RC; Chiang JH; Chou YH; Rubesin SE; Wu HP; Jeng WC; Hsu CC; Tiu CM; Chang T 《Radiology》1994,193(2):539
8.
MGC Hendriks P Dogterom JT Ebels B Oosterhuis LR Geertsema T Hulot G Bianchetti and JHG Jonkman 《Fundamental & clinical pharmacology》1998,12(5):559-565
Summary— In the present study we have compared the steady state biopharmaceutic characteristics of four diltiazem once daily controlled release capsules: Mono-Tildiem LP 300® (300 mg), Adizem® XL (300 mg)1, Cardizem® (300 mg) and Dilacor® (240 mg). Sixteen healthy male volunteers (aged 22.9 ± 3.3 years, range 19–31 years) completed an open label, multiple oral dose, randomized, four-period crossover study without a washout period in between. The volunteers received each diltiazem formulation once daily for four days. Trough diltiazem and metabolites plasma concentrations were determined on days 3 and 4. The 24-h plasma concentration-time profiles were assessed after the dose on day 4 of each period. The following steady state pharmacokinetic parameters for diltiazem were calculated: the minimum plasma concentration (cmin), the maximum plasma concentration (cmax), the time to reach that concentration (tmax), the time interval during which the plasma concentration exceeds 50% of cmax (t50), the area under the plasma concentration-time curve (AUC72–96) and the peak-to-trough fluctuation (PTF). For the metabolites of diltiazem, N-mono-desmethyl-diltiazem (NDM) and desacetyldiltiazem (DAD), AUC72–96 (AUCNDM and AUCDAD) and the ratio metabolite/parent compound were calculated. Steady state was achieved on day 3. Except one, all controlled release formulations have satisfactory controlled release properties allowing once daily administration. However, significant (P < 0.05) differences were found between the pharmacokinetic characteristics which do not allow exchange of the various formulations. Concentrations well below 50 ng·mL-1 in the morning hours were observed for Dilacor® (240 mg) and Adizem® XL (300 mg), which could be a disadvantage of these formulations as it is well-known that ischaemic events occur at a higher rate during that part of the day. The plasma concentration profiles of NDM and DAD, the major circulating metabolites, parallel the plasma concentration profiles for the parent compound. From a clinical point of view, all treatments were well tolerated. 相似文献
9.
Marcel F. Jonkman Frank M. Kauer Paul Nieuwenhuis Izaäk Molenaar† 《Artificial organs》1986,10(6):475-480
To investigate the possible use of a biodegradable microporous synthetic tube for fallopian tube replacement, polyetherurethane/poly-L-lactide (PU/PLLA) grafts in the uterine horn of the rat were studied and their patency and healing characteristics compared with those of nonbiodegradable polytetrafluoroethylene (PTFE; Teflon) grafts as well as with those of reanastomosed uterine horns. Regarding the healing characteristics, the PU/PLLA grafts were superior to the PTFE graft, as was indicated by the regeneration of endometrium and the extensive perigraft tissue ingrowth. However, the graft/uterine anastomoses of the PU/PLLA and PTFE grafts became obstructed by a plug of mucosal folds, all reanastomosed, uterine horns in the control experiments remaining open. In conclusion, although biodegradable microporous PU/PLLA uterine horn grafts have better healing characteristics than PTFE grafts, they easily obstruct at the graft/uterine junction. Mucosal suturing and/or the use of splints may contribute to the feasibility of biodegradable microporous artificial fallopian tubes in tubal surgery. 相似文献
10.